ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1966

Active PMR and GCA Is Associated with Changes in Monocyte Subset Composition

Qi Wang1, Kornelis S.M. van der Geest2, Wayel H. Abdulahad1, Johanna Westra3, Annemieke M.H. Boots1 and Elisabeth Brouwer1, 1Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 2Hanzeplein 1, Hpc: Aa21, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Aging, giant cell arteritis, Inflammation, monocytes and polymyalgia rheumatica

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Vasculitis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two closely related syndromes affecting older people. Proinflammatory cytokine IL-6 is found increased in both GCA/PMR patients and in the aged healthy population[1]. Pro-inflammatory monocytes, identified by CD16 and CD14 expression, increase with age and are potent producers of IL-6[2]. Importantly, monocyte-derived macrophages have been identified in the inflamed arteries of GCA and contribute to the immunopathology of GCA[3].  Yet, peripheral monocyte subsets are less well studied in GCA and PMR patients. In the current study, we assessed the distribution of different monocyte subsets in newly diagnosed GCA  and PMR patients before and after glucocorticoid (GC) treatment.

Methods: Peripheral blood samples of 16 newly-diagnosed GCA patients, 17 newly-diagnosed PMR patients and 16 age-matched, healthy controls (HCs) were studied. In a prospective, longitudinal study design, samples were obtained from 12 GCA and 10 PMR patients who were in remission after 12 weeks of treatment with GCs. Absolute numbers of total monocytes and classical(CD14brightCD16–), intermediate(CD14brightCD16dim) and non-classical(CD14dimCD16bright) monocytes were determined by truecount and flow cytometry. 

Results: Total numbers of circulating monocytes were increased in newly-diagnosed PMR patients but not in GCA patients when compared to age-matched HCs. Following 12 weeks of GC treatment, monocyte numbers normalized in PMR patients. When analysing absolute numbers of classical, intermediate and non-classical monocytes, we found the classical monocytes increased in PMR. No significant changes were noted in GCA. GC treatment in GCA tended to decrease numbers of non-classical monocytes (p=0.091).

When analysing relative changes in monocyte composition, the increase in classical monocytes in PMR was mirrored by a relative decrease of non-classical monocytes while proportions of intermediate type monocytes were unchanged. Interestingly, although we did not detect significant changes in absolute numbers, a similar decrease of non-classical monocytes was observed in newly diagnosed GCA patients. Moreover, GC treatment of GCA led to a further relative decrease of non-classical monocytes only.

Conclusion: We are the first to show that peripheral monocyte numbers are modulated during active PMR but not GCA. Treatment with GCs normalised monocyte numbers in PMR. Active disease in both PMR and GCA led to changes in monocyte composition showing decreases of non-classical monocytes. Different dynamics of monocyte subset distribution in PMR and GCA may help to unravel disease pathogenesis. Additional studies on different subsets of monocytes in GCA and PMR are ongoing.

References:

  1. van der Geest K.S.M, et al. “Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.” Rheumatology (2015)
  2. Nyugen J., et al. “Impaired functions of peripheral blood monocyte subpopulations in aged humans.” Journal of clinical immunology 30.6 (2010): 806-813.
  3. Rittner H.L., et al: Tissue-destructive macrophages in giant cell arteritis. Circulation research 1999, 84(9):1050-1058.

Disclosure: Q. Wang, None; K. S. M. van der Geest, None; W. H. Abdulahad, None; J. Westra, None; A. M. H. Boots, None; E. Brouwer, Abbvie, 2,Pfizer Inc, 2.

To cite this abstract in AMA style:

Wang Q, van der Geest KSM, Abdulahad WH, Westra J, Boots AMH, Brouwer E. Active PMR and GCA Is Associated with Changes in Monocyte Subset Composition [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/active-pmr-and-gca-is-associated-with-changes-in-monocyte-subset-composition/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/active-pmr-and-gca-is-associated-with-changes-in-monocyte-subset-composition/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology